A phase II randomized trial in completely resected Non-Small-Cell Lung Cancer comparing paclitaxel / carboplatin with docetaxel / cisplatin TORG0503
Phase 3
- Conditions
- on-Small-Cell Lung Cancer
- Registration Number
- JPRN-UMIN000001244
- Lead Sponsor
- Thoracic Oncology Research Group (TORG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1) not recovered from surgical complications 2) active infection such as bacterial infection 3) patients with interstitial pneumonitis or pulmonary fibrosis, as determined by chest CT 4) patients with myocardial infarction within 6 months 5) patients with uncontrolled complications 6) grade 2 or greater peripheral neuropathy 7) active concomitant malignancy 8) pregnant or lactating women 9) past history of allergic reactions to polysorbate 80 10) pneumonectomy 11) bronchoplasty 12) other conditions not suitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method